MOSCOW (BLOOMBERG) – Facing a rising wave of Covid-19 infections and a vaccination rate that isn’t keeping up, the Kremlin is trying to contain the epidemic without alarming Russians. Even insiders worry it won’t succeed.
Unofficial government statistics show the third wave has begun, according to two officials with knowledge of the situation, who asked not to be identified in order to speak candidly. Months of upbeat assessments from the Kremlin that the situation is under control have depressed demand for vaccines, as much of the population no longer fears the virus, the officials said.
Moscow’s seven-day average of new infections is at the highest since January and it’s adding cases faster than the UK, which has more than five times the population. The national total has stalled at around 9,000 new daily cases, down from nearly 30,000 in December.
Russia is publicly projecting confidence over its handling of the pandemic after President Vladimir Putin rejected a second lockdown in favor of prioritizing the economy when infections surged last year, in contrast to many European leaders. While the economy is rebounding, it has come at the cost of one of the world’s highest death tolls.
The government continues to reject new domestic restrictions, though it recently barred travel to some popular tourist destinations including Turkey to reduce risks from imported strains.
Putin on Friday ordered weekdays made non-working between Russia’s May 1 and May 9 holidays after officials said it would help reduce the spread of the virus by curbing travel.
“The new trend points to the situation possibly becoming more difficult,” Anna Popova, head of Russia’s public health watchdog, told the president.
Persuading Russians to take one of three domestic vaccines developed against Covid-19 is proving a harder task amid ingrained public skepticism toward officials. Moscow has resorted to offering gift cards worth 1,000 rubles (S$17) to motivate people aged over 60 to get their shots.
About two-thirds of Russians say they don’t want to have the vaccine, said Denis Volkov, an analyst at the independent Levada Center pollster. “Many people say, ‘why